title: Systemic lupus erythematous exacerbation following cessation of belimumab treatment: comments on the article by Furer et al.
authors.affiliation: a Department of Systemic Autoimmune Diseases , Hospital Clinic of Barcelona , Barcelona , Spain.
authors.forename: S
authors.initials: S
authors.lastname: Carbajal
authors.affiliation: a Department of Systemic Autoimmune Diseases , Hospital Clinic of Barcelona , Barcelona , Spain.
authors.forename: C
authors.initials: C
authors.lastname: Zamora-Martínez
authors.affiliation: a Department of Systemic Autoimmune Diseases , Hospital Clinic of Barcelona , Barcelona , Spain.
authors.forename: S
authors.initials: S
authors.lastname: Prieto-González
authors.affiliation: b Department of Nephrology , Hospital Clinic of Barcelona , Barcelona , Spain.
authors.forename: L F
authors.initials: LF
authors.lastname: Quintana
authors.affiliation: a Department of Systemic Autoimmune Diseases , Hospital Clinic of Barcelona , Barcelona , Spain.
authors.forename: G
authors.initials: G
authors.lastname: Espinosa
authors.affiliation: a Department of Systemic Autoimmune Diseases , Hospital Clinic of Barcelona , Barcelona , Spain.
authors.forename: R
authors.initials: R
authors.lastname: Cervera
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007166:Immunosuppressive Agents; D008180:Lupus Erythematosus, Systemic
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents